# Flux balance analysis

This article provides insufficient context for those unfamiliar with the subject. (Learn how and when to remove this template message) |

This article or section is in need of attention from an expert on the subject.Please help recruit one or improve this article yourself. See the talk page for details. Please consider using {{Expert-subject}} to associate this request with a WikiProject |

Please help improve this article by expanding it.Further information might be found on the talk page or at requests for expansion. This article has been tagged since January 2007. |

**Flux balance analysis** (**FBA**) has been shown to be a very useful technique for analysis of metabolic capabilities of cellular systems. A chemical system can be described by a set of differential equations. For instance,
suppose a chemical system has two reactions: A + B -> C at rate V1 and C -> A at rate V2. This system ccan be described by the differential equations: d(A)/dt = V2 + V1, d(B)/dt = -V1, and d(C)/dt = V1 - V2. A system is at steady state when all three derivatives (rates of change) are 0. FBA involves carrying out a steady state analysis, using the stoichiometric matrix for the system in question.

## Overview

The system is assumed to be optimised with respect to functions such as maximisation of biomass production or minimisation of nutrient utilisation, following which it is solved to obtain a steady state flux distribution. This flux distribution is then used to interpret the metabolic capabilities of the system. The dynamic mass balance of the metabolic system is described using the stoichiometric matrix, relating the flux rates of enzymatic reactions, to time derivatives of metabolite concentrations, as

where signifies the internal fluxes, represents the exchange fluxes in the system and is the number of external metabolites in the system. At steady state,

Therefore, the required flux distribution belongs to the null space of . Since , the system is under-determined and may be solved for fixing an optimisation criterion, following which, the system translates into a linear programming problem:

where represents the objective function composition, in terms of the fluxes. Further, we can constrain:

which necessitates all internal irreversible reactions to have a flux in the positive direction and allows exchange fluxes to be in either direction. Practically, a finite upper bound can be imposed, so that the problem does not become unbounded. This upper bound may also be decided based on the knowledge of cellular physiology.

## Perturbations

FBA also has the capabilities to address effect of gene deletions and other types of perturbations on the system. Gene deletion studies can be performed by constraining the reaction flux(es) corresponding to the gene(s) (and therefore, of their corresponding proteins(s)), to zero. Effects of inhibitors of particular proteins can also be studied in a similar way, by constraining the upper bounds of their fluxes to any defined fraction of the normal flux, corresponding to the extents of inhibition.

## References

- Bonarius HPJ, Schmid G, Tramper J (1997) Flux analysis of underdetermined metabolic networks: The quest for the missing constraints.
*Trends Biotech***15**: 308–314. - Forster J, Famili I, Fu P, Palsson BO, Nielsen J (2003) Genome-scale reconstruction of the
*Saccharomyces cerevisiae*metabolic network.*Genome Res***13**: 244–253. - Edwards JS, Palsson BO (2000) The
*Escherichia coli*MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities.*Proc Natl Acad Sci U S A***97**: 5528–5533. - Edwards JS, Covert M, Palsson BO (2002) Metabolic modelling of microbes: The flux-balance approach.
*Environ Microbiol***4**: 133–133. - Kauffman KJ, Prakash P, Edwards JS (2003) Advances in flux balance analysis.
*Curr Opin Biotech***14**: 491–496. - Alvarez-Vasquez F, Sims K, Cowart L, Okamoto Y, Voit E, et al. (2005) Simulation and validation of modelled sphingolipid metabolism in Saccharomyces cerevisiae.
*Nature***433**: 425–430. - Edwards JS, Ibarra RU, Palsson BO (2001)
*In silico*predictions of Escherichia coli metabolic capabilities are consistent with experimental data.*Nat Biotechnol***19**: 125–130. - Raman K, Rajagopalan P, Chandra N (2005) Flux Balance Analysis of Mycolic Acid Pathway: Targets for Anti-Tubercular Drugs.
*PLoS Comput Biol***1(5)**: e46